![]() |
Volumn 33, Issue 12, 2001, Pages 1968-1974
|
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria
a a a b a c d b |
Author keywords
[No Author keywords available]
|
Indexed keywords
HALOFANTRINE;
TAFENOQUINE;
ABDOMINAL PAIN;
ADULT;
ANTIMALARIAL ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
GASTRITIS;
GASTROENTERITIS;
HEADACHE;
HEMOLYSIS;
HUMAN;
KENYA;
MAJOR CLINICAL STUDY;
MALARIA;
MALE;
MUSCULOSKELETAL DISEASE;
MYALGIA;
PARASITE CONTROL;
PHARYNGITIS;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SKIN DISEASE;
STATISTICAL ANALYSIS;
ADOLESCENT;
ADULT;
AMINOQUINOLINES;
ANIMALS;
ANTIMALARIALS;
CHEMOPREVENTION;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALARIA, FALCIPARUM;
MALE;
MIDDLE AGED;
PLASMODIUM FALCIPARUM;
TREATMENT OUTCOME;
|
EID: 0035893187
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/324081 Document Type: Article |
Times cited : (162)
|
References (14)
|